Windtree Therapeutics, Inc. (WINT) Analysis

Windtree Therapeutics (WINT) announced that the Company has completed national phase filings of patent applications around the world, including in the United States, Germany, France, Italy, Japan and China. “Windtree continues to prepare for the potential of istaroxime in treating cardiogenic shock patients by expanding and strengthening our patent estate,” said Craig Fraser, Chairman and Chief Executive Officer of Windtree. “Unique aspects of istaroxime are utilized in our strategy for intellec

Hope everyone had a great trading day! We've had a pretty eventful week so far, and we have a lot to look forward to ahead. I wanted to share my screener that picked up some other plays that I am definitely going to be watching tomorrow morning and the rest of the week. I have no intentions of buying these as of right now, but defitnly will have volatility (could be up or down) making for some great trades. Please take a gander if you would like. And please be careful trading as always. Let me k...